CLINICAL_TRIALS
trial_result
· 2014-07-14
Clinical Trial Update: A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI [Phase 2]
Summary
Phase 2 study assessing pharmacokinetics of ramucirumab in combination with FOLFIRI in solid tumors; completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Solid Tumors | Phase 2 | Status: COMPLETED | Results posted: 2014-07-14